Advertisement
Review

HIV Treatment as Prevention: Considerations in the Design, Conduct, and Analysis of Cluster Randomized Controlled Trials of Combination HIV Prevention

  • Marie-Claude Boily mail,

    mc.boily@imperial.ac.uk

    Affiliation: Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London, United Kingdom

    X
  • Benoît Mâsse,

    Affiliation: CHU Sainte-Justine Research Centre, University of Montreal, Montreal, Quebec, Canada

    X
  • Ramzi Alsallaq,

    Affiliation: College of Nursing Global, New York University, New York, New York, United States of America

    X
  • Nancy S. Padian,

    Affiliations: Office of the US Global AIDS Coordinator, US Department of State, Washington, District of Columbia, United States of America, Department of Epidemiology, University of California, Berkeley, California, United States of America

    X
  • Jeffrey W. Eaton,

    Affiliation: Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London, United Kingdom

    X
  • Juan F. Vesga,

    Affiliation: Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London, United Kingdom

    X
  • Timothy B. Hallett

    Affiliation: Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London, United Kingdom

    X
  • Published: July 10, 2012
  • DOI: 10.1371/journal.pmed.1001250
  • Published in PLOS Medicine

Viewed info

Cited info

Saved info

Discussed info

Questions or concerns about usage data? Please let us know.